Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

NCT02218697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

357

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influsplit™ Tetra (Fluarix™ Tetra)
BIOLOGICAL: Pneumovax™ 23
BIOLOGICAL: Placebo (Saline)

Sponsor

GlaxoSmithKline